Takeda benoemt James Kehoe tot financieel topman
OSAKA, Japan–(BUSINESS WIRE)– Takeda Pharmaceutical Company Limited heeft vandaag bekendgemaakt dat James Kehoe is benoemd tot de nieuwe financieel topman van Takeda. De benoeming treedt op 15 juni 2016 in werking. Kehoe werkt vanuit Tokyo, onder de directe verantwoordelijkheid van president en ceo Christophe Weber.
“James Kehoes passie voor transformaties van grote organisaties ten behoeve van betere prestaties komt hem goed van pas wanneer hij het internationale financeteam gaat leiden voor verhoogde prestaties en de verwezenlijking van Takeda’s groeiambities”, zei Weber. “We zijn ook van mening dat James’ waarden goed overeenkomen met die van Takeda en dat zijn persoonlijke stijl goed klikt met het bestuur en de financiële top van Takeda.”
Takeda Appoints New Chief Financial Officer, James Kehoe
OSAKA, Japan–(BUSINESS WIRE)– Takeda Pharmaceutical Company Limited (“Takeda”) (TOKYO:4502) today announced the appointment of James Kehoe as Takeda’s new Chief Financial Officer and Corporate Officer, effective on June 15, 2016. Mr. Kehoe will be based in Tokyo and reports directly to Christophe Weber, President & CEO of Takeda.
“James Kehoe’s passion for transforming large organizations to achieve higher performance will hold him in good stead as he leads the Global Finance team to further elevate the company’s business performance and help Takeda deliver its growth ambitions,” said Christophe Weber, President & CEO of Takeda. “We also believe that James’s values are very much aligned with Takeda’s values and that his personal style will work well with the Takeda Executive Team and the Finance Leadership Team.”
Mr. Kehoe is an accomplished finance executive from the Consumer Goods sector. He is a strong business leader, with a track record of improving operational business performance that includes process optimization. He joins Takeda from Kraft Foods Group in the U.S., where he most recently held the role of CFO. Prior to that, he has held a number of finance-related positions spanning the course of more than 20 years, with assignments based in Germany, Switzerland and Italy.
An Irish national, Mr. Kehoe holds a Bachelor of Commerce degree from the University College, Galway, Ireland, and an MSc in Finance from the University College Dublin, Ireland.
| [ Reference: Career History of James Kehoe ] | |||||
| 2015-2015 |
KRAFT FOODS GROUP (Food) |
USA | |||
| Chief Financial Officer & Executive Vice President | |||||
| 2015-2015 |
GILDAN ACTIVEWEAR (Clothes) |
Canada | |||
| Chief Financial Officer & Executive Vice President | |||||
| 2013-2014 |
MONDELEZ (Food) |
USA | |||
| Senior Vice President, Operating Excellence | |||||
| 1988-2013 |
KRAFT FOODS (Food) |
USA etc. | |||
| Senior Vice President, Corporate Finance etc. | |||||
| 1986-1988 |
BERGER PAINTS (Paint material) |
Ireland, Republic of (Eire) | |||
| Cost Accountant | |||||
| 1984-1986 |
CANADA DRY CORPORATION (Food) |
Ireland, Republic of (Eire) | |||
| Assistant Management Accountant | |||||
About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited is a global, R&D-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its research efforts on oncology, gastroenterology and central nervous system therapeutic areas. It also has specific development programs in specialty cardiovascular diseases as well as late-stage candidates for vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology and gastroenterology, as well as its presence in emerging markets, fuel the growth of Takeda. More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries. For more information, visit http://betterhealth.takeda.com/.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160511006679/en/
Contacts
Takeda Pharmaceutical Company Limited
Investor Relations
Noriko Higuchi, +81-(0)3-3278-2306
noriko.higuchi@takeda.com
or
Media Relations
Tsuyoshi Tada, +81-(0)3-3278-2417
tsuyoshi.tada@takeda.com